Digestive system involvement of novel coronavirus infection: Prevention and control infection from a gastroenterology perspective

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), or coronavirus disease 2019 (COVID19), is a highly infectious respiratory virus that emerged in Wuhan, China and has posed a serious threat to human health worldwide since December 2019. As of March 31, 2020, a total of 697 244confirmed cases including 33 257 deaths have been reported for COVID-19 in a growing number of international locations (available from https://www.who.int/emergencies/diseases/novelcoronavirus-2019). The most common presentations of corvid-19 include fever and respiratory symptoms, such as cough, shortness of breath and dyspnea

[mks_button size=”large” title=”Download PDF” style=”squared” url=”https://clinicalhealthjournal.com/wp-content/uploads/2020/09/Digestive-system-involvement-of-novel.pdf” target=”_self” bg_color=”#000000″ txt_color=”#FFFFFF” icon=”” icon_type=”” nofollow=”0″]